当前位置: 首页 > 详情页

Quetiapine prevents A(25-35)-induced cell death in cultured neuron by enhancing brain-derived neurotrophic factor release from astrocyte

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [a]Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, [b]Department of Gastroenterology, First Affiliated Hospital, Henan University, Kaifeng, Henan, China [c]Department of Neurology, First Affiliated Hospital, Henan University, Kaifeng, Henan, China
出处:
ISSN:

关键词: astrocyte conditioned medium -amyloid cell viability neurotrophic factor

摘要:
-Amyloid (A)-induced neuronal toxicity is an early event in the pathogenesis of Alzheimer's disease. Quetiapine (QTP) is an atypical antipsychotic drug that has neuroprotectant properties, but little is known about its direct protective effects on neurons against the A-induced cell toxicity. In the present study, we investigated the neuroprotective effects of QTP on A(25-35)-induced cell death and the possible underlying mechanisms in primary cultures of neurons. Exposure of cortical neurons to 10M or more A(25-35) caused significant viability loss in a MTT assay, and the toxic effects were not significantly prevented by the simultaneous coadministration of QTP. However, pretreated astrocyte conditioned medium (ACM) with QTP (ACM(QTP)) for 24h markedly protected the neurons against the amyloid-induced cell loss. Furthermore, we revealed that QTP increased both the release of brain-derived neurotrophic factor from cultured astrocytes and the phosphorylation of extracellular signal-regulated kinase after 24h of treatment, which might be responsible for its protective effects on neurons. Consistent with the aforementioned findings, the protective effects of ACM on neurons could potentially be abolished by the extracellular signal-regulated kinase inhibitor and tropomyosin receptor kinase B receptor blocker. In conclusion, our data demonstrated that QTP exerted its neuroprotective effects against amyloid toxicity by enhancing the brain-derived neurotrophic factor release from astrocytes.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 神经科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 神经科学
JCR分区:
出版当年[2016]版:
Q4 NEUROSCIENCES
最新[2023]版:
Q4 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [a]Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, [c]Department of Neurology, First Affiliated Hospital, Henan University, Kaifeng, Henan, China
通讯作者:
通讯机构: [a]Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, [*1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院